Seroprevalencia y factores de riesgo de Toxoplasma gondii en Personas que Viven con VIH/SIDA  (PVVS) en el departamento de Cochabamba, Bolivia: Seroprevalencia y factores de riesgo de Toxoplasma gondii en personas con VIH

Amilcar Alejandro Flores Leon; Bertha Alanoca; Tania  Vargas Rivero; Gustavo Allende Larrain

doi:10.47993/gmb.v46i2.684

Authors

Amilcar Alejandro Flores Leon Laboratorio de Virologia- LABIMED
Bertha Alanoca Hospital Obrero No2 Caja Nacional de Salud (Cochabamba, Bolivia)
Tania Vargas Rivero Laboratorio de Virología - LABIMED, Facultad de Medicina, UMSS (Cochabamba, Bolivia)
Gustavo Allende Larrain IIBISMED, Facultad de Medicina, UMSS (Cochabamba, Bolivia)

DOI:

https://doi.org/10.47993/gmb.v46i2.684

Keywords:

HIV/AIDS, IgG antibodies, seroprevalence, risk factors, Toxoplasma gondii, PHLA

Abstract

Objective: To determine the seroprevalence and risk factors for chronic infection by T. gondii in people living with HIV/AIDS (PVVS) in the department of Cochabamba. Methods: observational-descriptive cross-sectional study. 325 samples (n=325) of plasma/serum from patients who attended LABIMED between the months of July to August of the year 2016 were used. Data (age, gender and risk factors) were collected in the sociodemographic form. Qualitative serological tests of Indirect Hemaglutination (HAI) and Indirect Immunoflorescence (IFI) were used the latter for confirmation of positive cases. Additionally, the count of CD4+ T lymphocytes was performed by flow cytometry to determine the immunological status of the patients that serves as a guide in clinical treatment. The data were analyzed with the program/software SPSS version 20.Results: The global seroprevalence of chronic infection by T. gondii in the study population was 40%. Consumption of undercooked meat (AOR: 2.85; 95% CI: 1.56-5.22) and farming/gardening activity (AOR: 1.7; 95% CI: 1.07-2, 70) were risk factors for chronic T. gondii infection. 45.6% of people living with the HIV/AIDS virus who are positive for toxoplasmosis have a CD4+ T lymphocyte count <200 cells/m³, equivalent to severe immunodeficiency. Conclusions: The study shows a significant seroprevalence of chronic infection by T. gondii, as well as presenting a high severe immunodeficiency in patients with the HIV/AIDS virus.

Metrics

Metrics Loading ...

References

Yohanes, T., Debalke, S. & Zemene, E. Latent toxoplasma gondii infection and associated risk factors among HIV-infected individuals at Arba Minch Hospital, south Ethiopia. AIDS Res. Treat. 2014, (2014). DOI: https://doi.org/10.1155/2014/652941

Mimica, F., Muñoz-Zanzi, C., Torres, M. & Padilla, O. Toxoplasmosis, zoonosis parasitaria prevalente en Chile: recuento y desafíos. Revista chilena de infectología 32, 541–549 (2015). DOI: https://doi.org/10.4067/S0716-10182015000600008

Anuradha, B. & Preethi, C. Seroprevalence of Toxoplasma IgG Antibodies in HIV Positive Patients in and Around Khammam, Telangana State. J. Clin. Diagn. Res. 8, DL01-2 (2014). DOI: https://doi.org/10.7860/JCDR/2014/9211.4880

Beran, O. et al. The Effect of Latent Toxoplasma gondii Infection on the Immune Response in HIV-Infected Patients. BioMed Research International 2015, 1–7 (2015). DOI: https://doi.org/10.1155/2015/271842

Ahmadpour, E. et al. Toxoplasmosis in immunocompromised patients in iran: A systematic review and meta-analysis. J. Infect. Dev. Ctries. 8, 1503–1510 (2014). DOI: https://doi.org/10.3855/jidc.4796

Ballesteros, D. A., Benavides, Y. L. & Cely, Alexandra Zipa, Cortes Liliana Jazmin, Gonzales, C. A. Comparación del cultivo “in vitro” de Toxoplasma gondii cepa RH en las líneas celulares Hep-2 y Vero. Rev. univ. salud 15, 209–217 (2013).

San Miguel, M., Ferreira, J., Figueredo, N., Fleitas, D. & Canese, A. Prevalencia de Toxoplasmosis y Chagas en pacientes con VIH / SIDA Prevalence of toxoplasmosis and Chagas disease in patients with HIV / AIDS. Rev. Inst. Med. Trop. 5, 10–15 (2010).

Sarmiento, M. C., Gomez, M. J. E. & Castano, O. J. C. Evaluación de la respuesta IgG anti- Toxoplasma y su avidez por western-blot en pacientes infectados por VIH. REV CUBANA MED TROP 57, 125–132 (2005).

Chemoh, W. et al. Toxoplasma gondii - Prevalence and risk factors in HIV-infected patients from Songklanagarind Hospital, Southern Thailand. Frontiers in Microbiology 6, 1–5 (2015). DOI: https://doi.org/10.3389/fmicb.2015.01304

Niguelie, C. Z., Hernández, Bojorge Santiago Solís, C. O. & González, M. C. Toxoplasmosis cerebral asociado a VIH-SIDA : Revisión de literatura y reporte de un caso. Revista Universidad y Ciencia 9, 1–10 (2016). DOI: https://doi.org/10.5377/uyc.v9i14.4556

Shen, G., Wang, X., Sun, H. & Gao, Y. Seroprevalence of Toxoplasma gondii Infection among HIV / AIDS Patients in Eastern China. Korean J Parasitol 54, 93–96 (2016). DOI: https://doi.org/10.3347/kjp.2016.54.1.93

Osunkalu, V. O. et al. Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital. HIV AIDS (Auckl) 3, 101–105 (2011). DOI: https://doi.org/10.2147/HIV.S15532

Tegegne, D., Abdurahaman, M., Mosissa, T. & Yohannes, M. Anti-Toxoplasma antibodies prevalence and associated risk factors among HIV patients. Asian Pac. J. Trop. Med. 9, 460–464 (2016). DOI: https://doi.org/10.1016/j.apjtm.2016.03.034

Domingos, A. et al. Seroprevalence of toxoplasma gondii igg antibody in HIV/AIDS-infected individuals in Maputo, Mozambique. Rev. Saude Publica 47, 890–896 (2013). DOI: https://doi.org/10.1590/S0034-8910.2013047004661

Taghi, R. M. et al. High Seroprevalence of Toxoplasma gondii Antibody in HIV/AIDS Individuals from North of Iran. Iran J Parasitol 10, 584–589 (2015).

Ministerio de salud; y Deportes. Programa Nacional ITS/VIH/SIDA. (2010).

Martínez-Oliva, B. G., Montaño-Valenzuela, K. J., Rodriguez-Herbas, P., Flores-León, A. A. & Grados-Torrez, R. E. Sensibilidad y especificidad de pruebas inmunocromatográficas utilizadas en el nuevo algoritmo de diagnóstico de VIH en Bolivia. Gac. Medica Boliv. 41, 6–8 (2018). DOI: https://doi.org/10.47993/gmb.v41i2.127

Protto, J. P., Schaaf, D., Suárez, M. F. & Darras, C. Entorno epidemiológico y respuesta a la epidemia del VIH en Bolivia. Rev Panam Salud Publica 23, 288–294 (2008). DOI: https://doi.org/10.1590/S1020-49892008000400012

Walle, F., Kebede, N., Tsegaye, A. & Kassa, T. Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia. Parasit. Vectors 6, 15 (2013). DOI: https://doi.org/10.1186/1756-3305-6-15

Sahu, A. et al. Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV. Clin. Proteomics 11, 39 (2014). DOI: https://doi.org/10.1186/1559-0275-11-39

Pérez, lazo G., Castillo, córdova R. & Maquera, A. J. Toxoplasmosis intramedular en una paciente con coinfección por VIH y tuberculosis. Rev Chilena Infectol 34, 77–80 (2017). DOI: https://doi.org/10.4067/S0716-10182017000100012

Fernandez, F. J., Aguilar, B. & Borges, I. Seroepidemiología de toxoplasmosis en habitantes de el viñedo, maracay, estado aragua. Comunidad y salud 13, 23–28 (2015).

Vasquez, D. et al. Encefalitis por toxoplasma en el contexto de pacientes inmunodeprimido (VIH/SIDA). Sinergias educativas (2020).

Casanova, S. P., Casanova, C. P. & Casanova, C. C. Toxoplasmosis cerebral durante la infección por el virus de inmunodeficiencia humana. Rev. Cubana Med. 41, 5 (2002).

Cardillo, N., Pasqualetti, M., Fariña, F. & Ribicich, M. La alimentación con carne cruda y el riesgo de transmisión de agentes parasitarios de importancia en la Salud Pública: Toxoplasma gondii y Trichinella spp. (2018).

Luyo, C. A., Pinedo, V. R., Chávez, V. A. & Casas, A. E. Factores Asociados a la Seroprevalencia de Toxoplasma gondii en Cerdos de Granjas Tecnificadas y No Tecnificadas de Lima, Perú. Rev. Investig. Vet. del Peru 28, 141–149 (2017). DOI: https://doi.org/10.15381/rivep.v28i1.12930

Dubey, J. P., Tiao, N., Gebreyes, W. A. & Jones, J. L. A review of toxoplasmosis in humans and animals in Ethiopia. Epidemiol. Infect. 140, 1935–1938 (2012). DOI: https://doi.org/10.1017/S0950268812001392

Rivera, F, N. & Garcia, D, P. El papel de los gatos en la toxoplasmosis. Dep. Microbiol. y Parasitol. Fac. Med. UNAM. Ciudad México, México 60, 7–18 (2017).

Lélu, M. et al. Quantitative estimation of the viability of Toxoplasma gondii oocysts in soil. Appl. Environ. Microbiol. 78, 5127–5132 (2012). DOI: https://doi.org/10.1128/AEM.00246-12